Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Danaher Corporation    DHR

DANAHER CORPORATION

(DHR)
  Report
Delayed Quote. Delayed Nyse - 02/20 04:04:33 pm
160.26 USD   -2.23%
04:16pDANAHER : Announces Quarterly Dividend
PR
02:48aCEO Discusses Virus, Cash Flow -- WSJ
DJ
02/19Correction to GE Cash Drain Article
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Summary
  • The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.
Strengths
  • The group's high margin levels account for strong profits.
  • Historically, the company has been releasing figures that are above expectations.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 144.33 USD
Weaknesses
  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • The group shows a rather high level of debt in proportion to its EBITDA.
  • Based on current prices, the company has particularly high valuation levels.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 39.09 times its estimated earnings per share for the ongoing year.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Ratings chart
Sector Advanced Medical Equipment & Technology - NEC
1st jan.Capitalisation (M$)Investor Rating
DANAHER CORPORATION6.80%113 999
THERMO FISHER SCIENTIFIC3.85%136 233
INTUITIVE SURGICAL, INC.4.01%71 316
BOSTON SCIENTIFIC CORPORATI..-4.87%59 962
EDWARDS LIFESCIENCES CORPOR..-1.61%49 079
ILLUMINA, INC.-8.60%44 570
SIEMENS HEALTHINEERS AG-5.15%43 750
KONINKLIJKE PHILIPS N.V.3.60%43 296
SHENZHEN MINDRAY BIO-MEDL E..--.--%40 789
AGILENT TECHNOLOGIES, INC.-0.61%26 524
RESMED13.97%25 542
CERNER CORPORATION4.59%23 944
OLYMPUS CORPORATION23.58%23 804
WATERS CORPORATION-7.34%13 960
HOLOGIC, INC.0.77%13 944
VARIAN MEDICAL SYSTEMS, INC..3.23%13 292
More Results
Financials (USD)
Sales 2020 21 310 M
EBIT 2020 4 052 M
Net income 2020 2 990 M
Debt 2020 19 898 M
Yield 2020 0,42%
P/E ratio 2020 39,1x
P/E ratio 2021 34,2x
EV / Sales2020 6,28x
EV / Sales2021 5,65x
Capitalization 114 B
Upcoming event on DANAHER CORPORATION
Surperformance© ratings
  Help  
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Valuation
Finances
Profitability
Earnings quality
Business Predictability
P/E ratio
Potential
Yield -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
RSI
Bollinger Spread
Unusual Volumes